Mass‐information: mephedrone, myths, and the new generation of legal highs
Zoe Davey, Ornella Corazza, Fabrizio Schifano, Paolo Deluca
Drugs and Alcohol Today August 30, 2010 DOI: 10.5042/daat.2010.0467 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Mephedrone Misinformation Popularity Internet privacy Recreational drug The internet European commission Harm reduction Risk analysis engineering Computer security Pharmacology European union Law World wide web |
| Citations | 30 |
| Key findings | The internet has been a key factor in the rapid expansion of the market in licit recreational drugs, particularly mephedrone and related cathinones, and the spread of misinformation about them poses challenges for harm reduction. |
Abstract
The market in licit recreational drugs is continuing to grow, both in the UK and elsewhere, and the internet has been acknowledged as a key factor in enabling this rapid expansion over the last few years. This is particularly true of the recent rise in popularity of the substance mephedrone (4-methylmethcathinone) and related cathinones. Keeping up to date with these new drugs and emerging trends is a challenge for both professionals and users, particularly given the relative paucity of balanced and reliable information available and the potential for misinformation to be widely disseminated. This article examines the transmission of inaccurate information in relation to mephedrone and substituted cathinones, and discusses the implication of this for harm reduction and future research, by looking at the results of the European Commission funded Psychonaut Web Mapping project, which used online resources to detect emerging trends, monitor their diffusion, and develop a reasonably accurate profile of these new psychoactive compounds.
Citations in the library
Cited by 7
- Clinical toxicology of newer recreational drugs Clinical Toxicology October 1, 2011
- Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom Journal of Clinical Psychopharmacology August 25, 2012
- The preclinical pharmacology of mephedrone; not justMDMAby another name British Journal of Pharmacology March 24, 2014
- An observational study on the sub-acute effects of mephedrone on mood, cognition, sleep and physical problems in regular mephedrone users Psychopharmacology June 26, 2018
- I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances. International Journal of Drug Policy February 1, 2017
and 2 more in the library